These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1690194)

  • 1. Deoxyspergualin directly suppresses antibody formation in vivo and in vitro.
    Fujii H; Takada T; Nemoto K; Yamashita T; Abe F; Fujii A; Takeuchi T
    J Antibiot (Tokyo); 1990 Feb; 43(2):213-9. PubMed ID: 1690194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of the humoral response induced by an anti-CD3 monoclonal antibody by deoxyspergualin in a murine model.
    Alegre ML; Sattar HA; Herold KC; Smith J; Tepper MA; Bluestone JA
    Transplantation; 1994 Jun; 57(12):1786-94. PubMed ID: 8016885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
    Hancock WW; Miyatake T; Koyamada N; Kut JP; Soares M; Russell ME; Bach FH; Sayegh MH
    Transplantation; 1997 Sep; 64(5):696-704. PubMed ID: 9311705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.
    Jung S; Toyka KV; Hartung HP
    Clin Exp Immunol; 1994 Dec; 98(3):494-502. PubMed ID: 7527745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice.
    Pai LH; FitzGerald DJ; Tepper M; Schacter B; Spitalny G; Pastan I
    Cancer Res; 1990 Dec; 50(24):7750-3. PubMed ID: 2253218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressant deoxyspergualin-induced inhibition of cell proliferation is accompanied with an enhanced reduction of tetrazolium salt.
    Odaka C; Toyoda E; Nemoto K
    J Antibiot (Tokyo); 1999 Jan; 52(1):45-51. PubMed ID: 10092197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of deoxyspergualin on mononuclear phagocytic system in mice.
    Asano K; Muramatsu K; Okamoto K
    Life Sci; 1996; 58(10):PL 171-5. PubMed ID: 8602108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation.
    Tepper MA; Nadler SG; Esselstyn JM; Sterbenz KG
    J Immunol; 1995 Sep; 155(5):2427-36. PubMed ID: 7650374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
    Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ
    J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suppressive effect of deoxyspergualin on the differentiation of human B lymphocytes maturing into immunoglobulin-producing cells.
    Morikawa K; Oseko F; Morikawa S
    Transplantation; 1992 Sep; 54(3):526-31. PubMed ID: 1329279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of antibody production by the immunosuppressive agent, 15-deoxyspergualin.
    Tepper MA; Petty B; Bursuker I; Pasternak RD; Cleaveland J; Spitalny GL; Schacter B
    Transplant Proc; 1991 Feb; 23(1 Pt 1):328-31. PubMed ID: 1990547
    [No Abstract]   [Full Text] [Related]  

  • 12. Deoxyspergualin preferentially inhibits the growth and maturation of anti-CD40-activated surface IgD+ B lymphocytes.
    Morikawa K; Nemoto K; Miyawaki T; Morikawa S
    Clin Exp Immunol; 1998 Jun; 112(3):495-500. PubMed ID: 9649221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of MPO-ANCA epitopes in SCG/Kj mice by 15-deoxyspergualin treatment restricted by IgG2b associated with crescentic glomerulonephritis.
    Tomizawa K; Nagao T; Kusunoki R; Saiga K; Oshima M; Kobayashi K; Nakayama T; Tanokura M; Suzuki K
    Rheumatology (Oxford); 2010 Jul; 49(7):1245-56. PubMed ID: 20378710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 15-deoxyspergualin on antibody secretion by specific isotypes producing B-cell hybridomas and myelomas.
    Sterbenz KG; Tepper MA
    Transplant Proc; 1994 Dec; 26(6):3218-20. PubMed ID: 7998121
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro IgG rheumatoid factor production by CD5-negative murine B cells in response to immune complexes of lipopolysaccharide.
    Taguchi H; Kanoh M; Takubo N; Kadota S; Kanazawa K; Shibata T; Utsumi S
    Clin Exp Immunol; 1990 Oct; 82(1):128-32. PubMed ID: 1698578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-deoxyspergualin prevents mucosal injury by inhibiting production of TNF-alpha and down-regulating expression of MD-1 in a murine model of TNBS-induced colitis.
    Lee J; Kim MS; Kim EY; Park HJ; Chang CY; Jung DY; Kwon CH; Joh JW; Kim SJ
    Int Immunopharmacol; 2007 Aug; 7(8):1003-12. PubMed ID: 17570317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of natural antibody synthesis by cyclophosphamide or 15-deoxyspergualin fails to prevent xenograft rejection in the guinea pig-to-rat model.
    Leventhal JR; Platt JL; Flores HC; Gruber SA; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):551. PubMed ID: 1566426
    [No Abstract]   [Full Text] [Related]  

  • 18. The immunosuppressant 15-deoxyspergualin [correction of 1,5-deoxyspergualin] reveals commonality between preT and preB cell differentiation.
    Wang B; Benoist C; Mathis D
    J Exp Med; 1996 Jun; 183(6):2427-36. PubMed ID: 8676063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressant deoxyspergualin induces apoptotic cell death in dividing cells.
    Odaka C; Toyoda E; Nemoto K
    Immunology; 1998 Nov; 95(3):370-6. PubMed ID: 9824499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.